Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Circulation|December 21, 2018
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Circulation. Cardiovascular Interventions|November 3, 2016
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
International Journal of Cardiology. Congenital Heart Disease|May 28, 2026
Changes in pharmacotherapy in adults with Fontan circulation and associations with outcomesAndrew M Freddo, Molly Eron, Antara Mondal, et al.
Science Advances|January 5, 2022
Dynamic detection and reversal of myocardial ischemia using an artificially intelligent bioelectronic medicinePatrick D Ganzer, Masoud S Loeian, Steve R Roof, et al.
Circulation|February 8, 2021
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 UpdateDominick J Angiolillo, Deepak L Bhatt, Christopher P Cannon, et al.
The Cochrane Database of Systematic Reviews|May 5, 2017
Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel diseaseClaudio A Bravo, Sameer A Hirji, Deepak L Bhatt, et al.
Circulation|March 23, 2005
Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot TrialShamir R Mehta, Philippe Gabriel Steg, Christopher B Granger, et al.
Circulation|October 29, 2008
Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trialsShamir R Mehta, William E Boden, John W Eikelboom, et al.
The New England Journal of Medicine|May 22, 2009
Early versus delayed invasive intervention in acute coronary syndromesShamir R Mehta, Christopher B Granger, William E Boden, et al.
JACC. Cardiovascular Interventions|November 26, 2025
Effect of Transcatheter Aortic Valve Replacement Program Ratings on Case SelectionTayyab Shah, Lin Yang, Yousuf Shah, et al.
Pageof 8